基因与细胞治疗
Search documents
近10亿,吉利资本领投了一家明星机器人公司丨投融周报
投中网· 2025-11-24 08:13
将投中网设为"星标⭐",第一时间收获最新推送 速览投资风口,掌握资本律动。 作者丨 长风 来源丨 东四十条资本 大家好,我是长风。今天给大家带来上周资本市场的专业投研信息。 焦点回顾: 机器人赛道,产业资本强势入场。 上周,绳驱AI机器人公司星尘智能(Astribot)完成数亿元 A++轮融资,由国科投资和蚂蚁集团联合领投,Bloom Advance Capital、时代伯乐(金马游乐产 业基金管理人)、南山战新投等知名财务机构及产业资本跟投,老股东锦秋基金继续追投。11月20 日,星动纪元完成近10亿元A+轮融资。本轮融资由吉利资本领投,北汽产投战略投资,北京市人工 智能产业投资基金及北京机器人产业发展投资基金联合注资;与此同时,已有多家国际产业巨头战略 资本加持。 大健康赛道,基因与细胞治疗(CGT)持续火热。 上周,中合基因完成数千万元PreA+轮融资,本 轮融资由国科创投和天津港保税区产业发展基金共同投资。点石资本担任本轮融资的独家财务顾问。 11月20日消息,瑞普晨创于近日完成5亿元A+轮融资。本轮融资的投资方包括国新基金、元生创 投、富浙资本、华睿投资、东方嘉富、荷塘创投、余杭国投、北京疆亘、贝橙 ...
元迈细胞生物科技获耐心资本支持
Nan Jing Ri Bao· 2025-06-24 02:28
Group 1 - Nanjing Yuanmai Cell Biotechnology Co., Ltd. has successfully received joint investment from the Nanjing University Technology Achievement Transformation Angel Fund and the Future Industry Angel Fund, marking the official launch of the Nanjing University Technology Achievement Transformation Angel Fund established in March this year [1] - Yuanmai Cell, founded in September 2022, focuses on the research and development of cell immunotherapy drugs, leveraging four core technology platforms: CAR-T module design, sequence screening, efficient gene delivery, and iPSC differentiation [1] - The founder, Professor Shen Pingping, is recognized as a leading authority in macrophage research and has received multiple funding supports from national and provincial programs, enhancing the company's research capabilities [1] Group 2 - The investment reflects the critical role of government-guided funds in accelerating the transformation of university scientific achievements into productive forces, thereby enhancing Nanjing's influence in the gene and cell therapy industry [2] - The Nanjing University Technology Achievement Transformation Angel Fund has a total scale of 500 million yuan, marking it as the first university technology achievement transformation fund in Jiangsu Province's strategic emerging industry special fund [2] - The fund aims to address the "last mile" challenge in transforming university scientific achievements into tangible productivity, with a focus on supporting projects in the biomedical and information communication sectors [3]